Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Innovent will supply sintilimab for the collaborated clinical trial
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
10+ emerging markets, Japan & ANZ transition in final phase
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Yesafili, received marketing authorization approval from the European Commission for the European Union
Total transaction value of the divestment is Rs. 3,660 million
Subscribe To Our Newsletter & Stay Updated
